Xintian Pharmaceutical: Controlling shareholder reduces company's shares by 1%, ownership percentage decreases.

New Tian Pharmaceuticals announced that its controlling shareholder, New Tian Zhiyao, plans to reduce its holdings by no more than 7.05 million shares on October 21, 2025, accounting for 2.9962% of the total share capital after excluding the shares held in the repurchase special account. As of November 12, New Tian Zhiyao has already reduced its holdings by 800,000 shares through centralized bidding transactions, accounting for 0.3277% of the total share capital of the company, and 0.3400% of the total share capital after excluding the shares held in the repurchase special account. After this reduction, its shareholding ratio decreased from 32.0809% to 31.7409%, triggering a change in equity of 1%, consistent with the previous reduction plan and commitments.